Biocryst Pharmaceuticals buy Evercore ISI
Start price
20.04.23
/
50%
€6.67
Target price
20.04.24
€9.11
Performance (%)
-38.50%
End price
21.04.24
€4.10
Summary
This prediction ended on 21.04.24 with a price of €4.10. Massive losses of -38.50% were the result for the BUY prediction by Evercore_ISI. Evercore_ISI has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | -0.760% | -0.760% | 20.518% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % |
Comments by Evercore_ISI for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target lowered by analysts at Evercore ISI from $13.00 to $10.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Evercore_ISI for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.73
13.01.25
13.01.25
€11.76
13.01.26
13.01.26
-25.83%
14.01.26
14.01.26
